DateNov. 10(Thu) 08:30 ~ 16:00
Place(5th floor) Park Ballroom CONRAD Seoul
| 09:00 ~ 09:25 |
Opening Remarks |
Yeong seop LeeCEO, News1 |
|
Congratulatory Remarks |
NAM In-SoonDeputy Speaker of the National Assembly LEE Man-heeChairperson of the Health and Welfare Committee, the National Assembly SEO Young-seokMember of the National Assembly KIM Kyo-heungMember of the National Assembly OH Yu-kyoungMinister of the Ministry of Food and Drug Safety (MFDS) |
|
|
Part 1 . Korean Drug Discovery and Medical Devices, Exploring the Path to Global Innovation |
||
| 09:25 ~ 09:50 |
Keynote 1 |
Cheong Jae-ho, M.D., Ph.D.Professor, Yonsei University College of Medicine |
| 09:50 ~ 10:15 |
Keynote 2 |
Keith Christopher, Ph.D.Director, JNPMEDI (Former USFDA) |
| 10:15 ~ 10:40 |
Keynote 3Taking Korean Advanced Medical Devices Global: From R&D to Clinical Practice and Markets |
KIM Beop-minDirector, Korea Medical Device Development Fund (KMDF) |
| 10:40 ~ 10:55 |
Beyond Weight Loss: Designing a Healthier Life |
KIM Na-youngVice President, Hanmi Pharmaceutical |
| 10:55 ~ 11:10 |
Lessons Learned in Drug Development through Yuhan’s Open Innovation Initiative |
CHOI Young-ki Managing Director, Yuhan Corporation |
| 11:10 ~ 11:25 |
Building on Drug Development Success, Enabling Sustained Innovation |
YANG Eun-youngHead of Bio Business Development, HLB Group |
| 11:25 ~ 11:40 |
SEERS: Building the Connected Hospital |
KANG Dae-yeopVice President, SEERS |
| 11:40 ~ 12:30 |
Panel Discussion |
[Moderator] PARK Mi-sunProject Manager, K-Health Future Initiative [Panel] Cheong Jae-ho, M.D., Ph.D.Professor, Yonsei University College of Medicine Keith Christopher, Ph.D.Director, JNPMEDI (Former USFDA) KIM Na-youngVice President, Hanmi Pharmaceutical CHOI Young-kiManaging Director, Yuhan Corporation YANG Eun-youngHead of Bio Business Development, HLB Group KANG Dae-yeopVice President, SEERS |
| 12:30 ~ 13:30 |
Lunch Time |
|
|
Part2. Stem Cells Bringing New Hope to K-Bio |
||
| 13:30 ~ 14:00 |
KeynoteNew Approach Methodologies: Genomics, Stem Cells, and AI for Drug Discovery |
Joseph C. WuDirector, Stanford Cardiovascular Institute Professor of Cardiovascular Medicine and Radiology, Stanford School of Medicine |
| 14:00 ~ 14:20 |
The Advanced Regenerative Medicine (ARM) policies and national support framework in South Korea |
CHOI KyungilDirector General of Bureau of Advanced Health Technology Policy, Ministry of Health and Welfare (MOHW) |
| 14:20 ~ 14:40 |
Achievements and Global Expansion of KFRM |
PARK Chang-Hwan, M.D., Ph.D.Korean Fund for Regenerative Medicine President, CEO |
| 14:40 ~ 14:55 |
IR Session 1Industrialization of iPSC-Based Regenerative Medicine: From Cell Line Platforms to Therapeutic Development |
NAM Yoo-junVice President, YiPSCELL |
| 14:55 ~ 15:10 |
IR Session 2Innovations in Stem Cell and Organoid Technologies : From Therapeutics to Evaluation Platforms |
LEE Seung-hee Director of Research Institute, Kangstem Biotech |
| 15:10 ~ 15:25 |
IR Session 3Industrializing Stem Cell Therapeutics: Taking an Off-the-Shelf Platform to the Global Market |
KIM Mi-hyungCEO, Anterogen |
| 15:25 ~ 16:30 |
Panel DiscussionNew Possibilities for Stem Cells: The Beginning and the Future |
[Moderator] PARK Chang-Hwan, M.D., Ph.D.Korean Fund for Regenerative Medicine President, CEO [Panel] Joseph C. WuDirector, Stanford Cardiovascular Institute Professor of Cardiovascular Medicine and Radiology, Stanford School of Medicine CHOI KyungilDirector General of Bureau of Advanced Health Technology Policy, Ministry of Health and Welfare (MOHW) NAM Yoo-junVice President, YiPSCELL LEE Seung-heeDirector of Research Institute, Kangstem Biotech KIM Mi-hyungCEO, Anterogen |
※ The above schedule is subject to change.